Page last updated: 2024-10-25

chlorpropamide and Neoplasm Metastasis

chlorpropamide has been researched along with Neoplasm Metastasis in 1 studies

Chlorpropamide: A sulfonylurea hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277)
chlorpropamide : An N-sulfonylurea that is urea in which a hydrogen attached to one of the nitrogens is substituted by 4-chlorobenzenesulfonyl group and a hydrogen attached to the other nitrogen is substituted by propyl group. Chlorpropamide is a hypoglycaemic agent used in the treatment of type 2 (non-insulin-dependent) diabetes mellitus not responding to dietary modification.

Neoplasm Metastasis: The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tenbaum, SP1
Ordóñez-Morán, P1
Puig, I1
Chicote, I1
Arqués, O1
Landolfi, S1
Fernández, Y1
Herance, JR1
Gispert, JD1
Mendizabal, L1
Aguilar, S1
Ramón y Cajal, S1
Schwartz, S1
Vivancos, A1
Espín, E1
Rojas, S1
Baselga, J1
Tabernero, J1
Muñoz, A1
Palmer, HG1

Other Studies

1 other study available for chlorpropamide and Neoplasm Metastasis

ArticleYear
β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer.
    Nature medicine, 2012, Volume: 18, Issue:6

    Topics: Animals; Apoptosis; beta Catenin; Cell Line, Tumor; Cell Nucleus; Chlorpropamide; Colonic Neoplasms;

2012